Preparation and biological studies of 68Ga-DOTA-alendronate

Preparation and biological studies of 68Ga-DOTA-alendronate

Objective(s): In line with previous research on the development of conjugated bisphosphonate ligands as new bone-avid agents, in this study, DOTA conjugated alendronate (DOTA-ALN) was synthesized and evaluated after labeling with gallium-68 (68Ga).Methods: DOTA-ALN was synthesized and characterized,...

Full description

Bibliographic Details
Main Authors:	Ashraf Fakhari, Amir Jalilian, Fariba Johari-daha, Mehdi Shafiee-Ardestani, Ali Khalaj
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2016-07-01
Series:	Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:	Ga-68 DOTA Alendronate Biodistribution radiolabeling
Online Access:	http://aojnmb.mums.ac.ir/article_7017_bcf673726592571ac5a6a9f91a721c41.pdf

Similar Items

Radiosynthesis and Animal Studies of 111In-DTPA-bis-alendronate Complex
by: Ashraf Fakhari, et al.
Published: (2015-09-01)

Preparation and Quality Control of 68Ga-Citrate for PET Applications
by: Ayuob Aghanejad, et al.
Published: (2015-07-01)

Standardized image quality for 68Ga-DOTA-TATE PET/CT
by: Christina P. W. Cox, et al.
Published: (2020-03-01)

Preclinical Assessment of a 68Ga-DOTA-Functionalized Depsipeptide as a Radiodiagnostic Infection Imaging Agent
by: Thomas Ebenhan, et al.
Published: (2017-08-01)

Labeling of DOTA-conjugated HPMA-based polymers with trivalent metallic radionuclides for molecular imaging
by: Elisabeth Eppard, et al.
Published: (2018-02-01)

[<sup>68</sup>Ga]Ga-DOTA-TOC: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging
by: Ute Hennrich, et al.
Published: (2020-03-01)

18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumor
by: Marcello Moro Queiroz, et al.
Published: (2021-05-01)

Evaluation of 68Ga-DOTA-Ubiquicidin (29–41) for imaging Staphylococcus aureus (Staph A) infection and turpentine-induced inflammation in a preclinical setting
by: Dilip Kumar Boddeti, et al.
Published: (2021-01-01)

Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
by: Junhao Wu, et al.
Published: (2021-09-01)

Application of the 68Ge/68Ga Generator in Clinic
by: HUANG Qian-huan1;PAN Dong-hui2;XU Yu-ping2;SHENG Jie1;WANG Yan-ting2;YANG Min1,2
Published: (2017-04-01)

Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report
by: Gennaro Nappo, et al.
Published: (2020-12-01)

Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform
by: Mohammad B. Haskali, et al.
Published: (2019-08-01)

68Ga-DOTA-FAPI-04 PET/CT as a Promising Tool for Differentiating Ovarian Physiological Uptake: Preliminary Experience of Comparative Analysis With 18F-FDG
by: Qixin Wang, et al.
Published: (2021-10-01)

Results of a Prospective Trial to Compare <sup>68</sup>Ga-DOTA-TATE with SiPM-Based PET/CT vs. Conventional PET/CT in Patients with Neuroendocrine Tumors
by: Lucia Baratto, et al.
Published: (2021-05-01)

Cost-Effectiveness Analysis of <sup>68</sup>Ga DOTA-TATE PET/CT, <sup>111</sup>In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors
by: Matthias Frank Froelich, et al.
Published: (2021-02-01)

Correlation between standardized uptake value of 68Ga-DOTA-NOC positron emission tomography/computed tomography and pathological classification of neuroendocrine tumors
by: Chalermrat Kaewput, et al.
Published: (2018-01-01)

Synthesis and Radiolabelling of DOTA-Linked Glutamine Analogues with 67,68Ga as Markers for Increased Glutamine Metabolism in Tumour Cells
by: Ivan Greguric, et al.
Published: (2013-06-01)

Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [<sup>177</sup>Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model
by: Judith Anna Delage, et al.
Published: (2021-01-01)

Comparative evaluation of 68Ga-labelled TATEs: the impact of chelators on imaging
by: Yuxiao Xia, et al.
Published: (2020-04-01)

Synthesis, Characterisation and Application of 68Ga-labelled Macromolecules
by: Velikyan, Irina
Published: (2005)

Clinically Applicable Cyclotron-Produced Gallium-68 Gives High-Yield Radiolabeling of DOTA-Based Tracers
by: Emma Jussing, et al.
Published: (2021-07-01)

Otto: a 4.04 GBq (109 mCi) 68Ge/68Ga generator, first of its kind - extended quality control and performance evaluation in the clinical production of [68Ga]Ga-PSMA-11
by: Nicole N. Waterhouse, et al.
Published: (2020-02-01)

Synthesis of DOTA-pyridine chelates for 64Cu coordination and radiolabeling of αMSH peptide
by: Hua Yang, et al.
Published: (2021-01-01)

Preclinical Assessment Addressing Intravenous Administration of a [<sup>68</sup>Ga]Ga-PSMA-617 Microemulsion: Acute In Vivo Toxicity, Tolerability, PET Imaging, and Biodistribution
by: Vusani Mandiwana, et al.
Published: (2021-04-01)

Chelator-Free/Chelator-Mediated Radiolabeling of Colloidally Stabilized Iron Oxide Nanoparticles for Biomedical Imaging
by: Sofia Papadopoulou, et al.
Published: (2021-06-01)

pH-Responsive Carboxymethylcellulose Nanoparticles for <sup>68</sup>Ga-WBC Labeling in PET Imaging
by: Anna Maria Piras, et al.
Published: (2019-10-01)

Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi<sup>8</sup>, Met(O<sub>2</sub>)<sup>11</sup>]-Substance P for Future Clinical Application: First Experiences
by: Janine Suthiram, et al.
Published: (2021-08-01)

A convenient and efficient total solid-phase synthesis of DOTA-functionalized tumor-targeting peptides for PET imaging of cancer
by: Subhani M. Okarvi, et al.
Published: (2019-09-01)

Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution
by: Gonçalo Ferreira, et al.
Published: (2019-05-01)

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
by: Paola Mapelli, et al.
Published: (2021-01-01)

Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC
by: Jean-Philippe Sinnes, et al.
Published: (2019-05-01)

Evaluation of Integrin α<sub>v</sub>β<sub>3</sub> Expression in Murine Xenograft Models: [<sup>68</sup>Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical Confirmation
by: Kosuke Mitsuyuki, et al.
Published: (2021-07-01)

Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
by: Benjamin Poret, et al.
Published: (2020-03-01)

Development of 111In-labeled porphyrins for SPECT imaging
by: Shaghayegh Sadeghi, et al.
Published: (2014-10-01)

The role of 68Ga-DOTA derivatives PET-CT in patients with ectopic ACTH syndrome
by: Filippo Ceccato, et al.
Published: (2020-04-01)

Estudo de materiais adsorvedores para o preparo de geradores de Ge-68/Ga-68
by: Tânia de Paula Brambilla
Published: (2013)

Estudo de materiais adsorvedores para o preparo de geradores de Ge-68/Ga-68
by: Brambilla, Tânia de Paula
Published: (2013)

Initial clinical experience with 68Ga-DOTA-NOC prepared using 68Ga from nanoceria-polyacrylonitrile composite sorbent-based 68Ge/68Ga generator and freeze-dried DOTA-NOC kits
by: Piyush Chandra, et al.
Published: (2017-01-01)

The Impact of 68Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours
by: Daniel J. Cuthbertson, et al.
Published: (2021-06-01)

Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
by: mojdeh naderi, et al.
Published: (2016-01-01)